Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZAI LAB LIMITED

(ZLAB)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 06/21 03:33:48 pm
159.185 USD   +1.20%
06/17Asian ADRs Move Higher in Thursday Trading
MT
06/17ZAI LABá : MacroGenics Sign Deal to Develop Cancer Antibodies
MT
06/16SECTOR UPDATE : Health Care Stocks Mixed In Premarket Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zai Lab : Prices Share Offering for Hong Kong, New York

04/21/2021 | 06:35am EDT


ę MT Newswires 2021
All news about ZAI LAB LIMITED
06/17Asian ADRs Move Higher in Thursday Trading
MT
06/17ZAI LABá : MacroGenics Sign Deal to Develop Cancer Antibodies
MT
06/16SECTOR UPDATE : Health Care Stocks Mixed In Premarket Trading
MT
06/16ZAI LABá : MacroGenics Partner to Develop Preclinical Bispecific Antibodies in O..
MT
06/16ZAI LABá : and MacroGenics Enter Into Broad Strategic Collaboration to Develop a..
PU
06/16ZAI LAB LTDá : Entry into a Material Definitive Agreement, Regulation FD Disclos..
AQ
06/16Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop a..
GL
06/11Asian ADRs Move Lower in Friday Trading
MT
06/02Zai Lab Partners with Mirati Therapeutics to Develop, Commercialize Experimen..
MT
06/01ZAI LABá : SVB Leerink Adjusts Price Target on Zai Lab to $202 From $192, Mainta..
MT
More news
Financials (USD)
Sales 2021 138 M - -
Net income 2021 -436 M - -
Net cash 2021 589 M - -
P/E ratio 2021 -29,2x
Yield 2021 -
Capitalization 14 929 M 14 929 M -
EV / Sales 2021 104x
EV / Sales 2022 42,0x
Nbr of Employees 1 194
Free-Float 98,9%
Chart ZAI LAB LIMITED
Duration : Period :
Zai Lab Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZAI LAB LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 214,50 $
Last Close Price 157,30 $
Spread / Highest target 67,2%
Spread / Average Target 36,4%
Spread / Lowest Target 21,1%
EPS Revisions
Managers and Directors
NameTitle
Ying Du Chairman & Chief Executive Officer
Tao Fu President, Chief Operating Officer & Director
Billy Cho Chief Financial Officer
Ning Xu Executive VP & Head-Clinical Operations
James Yan Chief Operating Officer-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ZAI LAB LIMITED16.29%14 929
CSL LIMITED7.89%104 078
WUXI BIOLOGICS (CAYMAN) INC.28.50%71 827
BIOGEN INC.58.64%58 481
SAMSUNG BIOLOGICS CO.,LTD.1.21%48 692
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.21.49%44 555